These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 23369448)

  • 41. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?
    Tsouli SG; Liberopoulos EN; Mikhailidis DP; Athyros VG; Elisaf MS
    Metabolism; 2006 Oct; 55(10):1293-301. PubMed ID: 16979398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate.
    See LC; Kuo CF; Chuang FH; Li HY; Chen YM; Chen HW; Yu KH
    J Rheumatol; 2009 Aug; 36(8):1691-8. PubMed ID: 19531754
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fructose Intake, Serum Uric Acid, and Cardiometabolic Disorders: A Critical Review.
    Caliceti C; Calabria D; Roda A; Cicero AFG
    Nutrients; 2017 Apr; 9(4):. PubMed ID: 28420204
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between uric acid, cancer incidence and mortality in patients with type 2 diabetes: Shanghai diabetes registry study.
    Deng Z; Gu Y; Hou X; Zhang L; Bao Y; Hu C; Jia W
    Diabetes Metab Res Rev; 2016 Mar; 32(3):325-32. PubMed ID: 26409171
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Xanthine oxidoreductase activity is associated with serum uric acid and glycemic control in hemodialysis patients.
    Nakatani A; Nakatani S; Ishimura E; Murase T; Nakamura T; Sakura M; Tateishi Y; Tsuda A; Kurajoh M; Mori K; Emoto M; Inaba M
    Sci Rep; 2017 Nov; 7(1):15416. PubMed ID: 29133805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Soluble Uric Acid Is an Intrinsic Negative Regulator of Monocyte Activation in Monosodium Urate Crystal-Induced Tissue Inflammation.
    Ma Q; Honarpisheh M; Li C; Sellmayr M; Lindenmeyer M; Böhland C; Romagnani P; Anders HJ; Steiger S
    J Immunol; 2020 Aug; 205(3):789-800. PubMed ID: 32561569
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolic and cardiovascular effects of chronic mild hyperuricemia in rodents.
    Park SK; Rosenthal TR; Williams JS; Shelton JM; Takahashi M; Zhang S; Bobulescu IA
    J Investig Med; 2018 Oct; 66(7):1037-1044. PubMed ID: 30042113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemia.
    Kuriyama S
    Clin Exp Nephrol; 2020 Mar; 24(Suppl 1):1-5. PubMed ID: 31754883
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Uric acid and oxidative stress: relative impact on cardiovascular risk?
    Strazzullo P; Puig JG
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):409-14. PubMed ID: 17643880
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum uric acid as a risk predictor for erectile dysfunction.
    Salem S; Mehrsai A; Heydari R; Pourmand G
    J Sex Med; 2014 May; 11(5):1118-24. PubMed ID: 24621054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between serum uric acid, metabolic syndrome and resting heart rate in Chinese elderly.
    Liu P; Jiang Y; Meng J
    Obes Res Clin Pract; 2016; 10(2):159-68. PubMed ID: 25957671
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Correlation between fasting C-peptide and serum uric acid in patients with type 2 diabetes mellitus].
    Liang Q; Wang XY; Hu HF; Lai JB; Yao WL; Chen ML; Rao X
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Apr; 38(4):490-495. PubMed ID: 29735453
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Time to Target Uric Acid to Retard Chronic Kidney Disease Progression.
    Uchida S; Kumagai T; Chang WX; Tamura Y; Shibata S
    Contrib Nephrol; 2018; 192():56-68. PubMed ID: 29393121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Baseline and changes in serum uric acid independently predict 11-year incidence of metabolic syndrome among community-dwelling women.
    Kawamoto R; Ninomiya D; Kasai Y; Senzaki K; Kusunoki T; Ohtsuka N; Kumagi T
    J Endocrinol Invest; 2018 Aug; 41(8):959-968. PubMed ID: 29460261
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dose-response relationship between distinct serum uric acid trajectories and metabolic syndrome risk: A 5-year prospective cohort study.
    Zhang S; Ma Z; Li Q; Liu J; Tao L; Han Y; Zhang J; Guo X; Yang X
    Nutr Metab Cardiovasc Dis; 2021 Apr; 31(4):1189-1199. PubMed ID: 33549428
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hyperuricemia as a potential plausible risk factor for periodontitis.
    Chen ZY; Ye LW; Zhao L; Liang ZJ; Yu T; Gao J
    Med Hypotheses; 2020 Apr; 137():109591. PubMed ID: 32007821
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study.
    Norvik JV; Storhaug HM; Ytrehus K; Jenssen TG; Zykova SN; Eriksen BO; Solbu MD
    BMC Cardiovasc Disord; 2016 May; 16():85. PubMed ID: 27165776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
    Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A
    Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE study.
    Oyama J; Tanaka A; Sato Y; Tomiyama H; Sata M; Ishizu T; Taguchi I; Kuroyanagi T; Teragawa H; Ishizaka N; Kanzaki Y; Ohishi M; Eguchi K; Higashi Y; Yamada H; Maemura K; Ako J; Bando YK; Ueda S; Inoue T; Murohara T; Node K;
    Cardiovasc Diabetol; 2016 Jun; 15():87. PubMed ID: 27317093
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum uric acid, the metabolic syndrome, and the risk of chronic kidney disease in patients with type 2 diabetes.
    Sheikhbahaei S; Fotouhi A; Hafezi-Nejad N; Nakhjavani M; Esteghamati A
    Metab Syndr Relat Disord; 2014 Mar; 12(2):102-9. PubMed ID: 24447037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.